Literature DB >> 1696924

Immunohistochemical profile of meningiomas and their histological subtypes.

A Artlich1, D Schmidt.   

Abstract

Seventy-seven cases of meningioma (15 with single or multiple recurrences), selected on the basis of their histologic subtypes, and nine cases of neurilemoma were analyzed immunohistochemically for the presence of the five classes of intermediate filament proteins, neuron-specific enolase (NSE), protein S-100, epithelial membrane antigen (EMA), and HNK-1 (Leu-7). Most antibodies were studied with the alkaline phosphatase-antialkaline phosphatase method. The peroxidase-anti-peroxidase and avidin-biotin-complex methods were used for Leu-7 and NSE, respectively. Meningiomas were subdivided into groups showing cytokeratin or protein S-100 positivity. Coexpression of these two markers was rare (5%) and occurred in meningotheliomatous meningiomas only. Only in these cases was cytokeratin expression more frequent than in meningiomas taken together (33% versus 20%). In contrast, protein S-100 expression was less frequent (46% versus 60% on average). In fibrous meningiomas, both cytokeratins and NSE were expressed less frequently than on average (11% versus 20%, 67% versus 88%, respectively). Protein S-100 occurred in a higher percentage of cases. Transitional meningiomas did not show cytokeratin expression. Protein S-100 occurred in a higher percentage of cases. Transitional meningiomas did not show cytokeratin expression. Protein S-100 was expressed slightly more often than in the other subtypes. Psam-momatous meningiomas coexpressed more markers than any other subtype. Hemangioblastic and hemangiopericytic forms did not stain for EMA, but otherwise showed a staining profile similar to that of meningiomas. HNK-1 was expressed in 29% of meningiomas, particularly among tumors with anaplastic histologic features. There was no marker that retrospectively indicated impending recurrences.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696924     DOI: 10.1016/0046-8177(90)90054-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Intracranial solitary fibrous tumors: A report of two cases and a review of the literature.

Authors:  Zi-Yan Wang; Kai Qiu; Yi-Hui Ma; Xiao-Tao Wang; Jian-Ji Bao; Zhi-Feng Zhang; Xian-Zhi Liu
Journal:  Oncol Lett       Date:  2015-12-02       Impact factor: 2.967

2.  Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma.

Authors:  Avninder Singh; Ashwani Kumar Mishra; Kris Ylaya; Stephen M Hewitt; Karam Chand Sharma; Sunita Saxena
Journal:  Pathol Oncol Res       Date:  2011-09-10       Impact factor: 3.201

Review 3.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

4.  High throughput screening of meningioma biomarkers using a tissue microarray.

Authors:  Eriks A Lusis; Michael R Chicoine; Arie Perry
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

5.  An immunohistochemical study on HLA-DR expression in human meningiomas.

Authors:  N Ohara; K Hayashi; K Miyake; H J Jeon; K Takahashi; T Akagi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 6.  Meningioma.

Authors:  Ali-Reza Fathi; Ulrich Roelcke
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

7.  Posterior mediastinal ectopic meningioma: a case report.

Authors:  Chenying Lu; Xianghua Hu; Min Xu; Weibo Mao; Hongyuan Yang; Zufei Wang; Jiansong Ji
Journal:  World J Surg Oncol       Date:  2015-04-22       Impact factor: 2.754

8.  Metastatic meningioma presenting as cancer of unknown primary.

Authors:  Vinay Gupta; Wilson I Gonsalves; Steven I Robinson
Journal:  Rare Tumors       Date:  2013-12-16

9.  Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study.

Authors:  Eman Abdelzaher; Dina Mohamed Abdallah
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

Review 10.  Meningioma recurrence.

Authors:  Tibor Hortobágyi; János Bencze; Gréta Varkoly; Mahan C Kouhsari; Álmos Klekner
Journal:  Open Med (Wars)       Date:  2016-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.